2021 · Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · open access
Expanding access to SARS-CoV-2 IgG and IgM serologic testing using fingerstick whole blood, plasma, and rapid lateral flow assays
Anderson et al.
The finding, in our words
Fingerstick plasma collected in Microtainer tubes showed 100% concordance with matched venous plasma on the Abbott ARCHITECT SARS-CoV-2 IgG assay, n=109. Fingerstick dried blood spots found high concordance with venous samples, n=61, supporting these microsampling methods for decentralised serology.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.
A study of decentralised patient-centric microsampling found that 82% of untrained participants, 47 of 57, successfully self-collected acceptable fingerstick blood in Microtainer tubes. All 46 tested samples yielded accurate HIV viral suppression results compared to venipuncture, though this remote monitoring approach is limited to US courier services and temperature conditions.
The study demonstrated that qPCR-based epigenetic immune cell counting from capillary dried blood spots agreed with venous blood and conventional flow cytometry in healthy donors, and then identified lymphopenia, neutrophilia and a lowered lymphocyte-to-neutrophil ratio in 103 COVID-19 patients versus 113 healthy controls, with naive B cell frequency tracking disease severity, suggesting that filter-paper blood collection could enable remote immune monitoring in home-isolated patients.
Capillary blood self-sampling showed near-perfect agreement with venous sampling for SARS-CoV-2 IgG detection, achieving a Cohen's kappa of 0.88. Samples remained stable at room temperature for seven days, and 38 of 39 participants successfully collected adequate volumes, supporting its use for decentralised serological testing.
The study validated a semi-quantitative protocol for Epstein-Barr virus serology using dried blood spots, demonstrating 98.8% sensitivity and 96.5% specificity compared to paired venous serum samples. The successful validation in a self-sampling cohort confirms the suitability of this patient-centric microsampling approach for large-scale seroprevalence studies and decentralised trials.
Capillary blood samples collected by staff or self-collected by participants showed strong correlation and clinically acceptable agreement with venipuncture for influenza haemagglutination inhibition titers. The small differences observed were not clinically meaningful, and adequate sample volume was achieved in most attempts, supporting the feasibility of decentralised serological testing.